Existing cancer drugs spread their wings


What if a skin cancer drug might also work in breast cancer patients? Researchers investigate how to expand the use of existing cancer drugs to new patient groups, with the use of whole genome sequencing. Netherlands Cancer Institute researcher Daphne van der Velden describes the first results in her PhD thesis, which she defended on December 6th.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.